FISV › analyze
FISV · Analyze
A portfolio-specific passage was removed from the public build.
The Short Version
Fiserv suffered a violent de-rating event on October 29, 2025 — a 44% single-day collapse triggered by a -24.3% Q3 EPS miss and guidance cut. The root cause: an Argentina inflation tailwind faded, and prior CEO Bisignano had deferred investment to artificially sustain margins, leaving the company unable to compensate. This is an execution failure, not a moat failure. The banking tech business — 42% of US banks, 95%+ retention, 5-7 year contracts — is intact. New management (CEO Lyons + CFO Todd from GPN + new co-presidents) is credible and buying stock. At 7.8x P/FCF and 6.79x forward P/E, you are paying a bargain price for a durable moat business. 2026 is a transition year. If H2 2026 margin recovery materializes, this re-rates significantly.
Conviction: 7/10 | Action: HOLD; add $52-60 on weakness, especially if H2 guidance reaffirmed at Q1 earnings
Phase 1: Fundamentals
Income Statement
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue ($M) | $17,737 | $19,093 | $20,456 | $21,193 |
| Gross Profit ($M) | $9,745 | $11,423 | $12,443 | $12,581 |
| Gross Margin | 54.9% | 59.8% | 60.8% | 59.4% |
| Operating Income ($M) | $3,686 | $4,847 | $5,879 | $5,698 |
| Operating Margin | 20.8% | 25.4% | 28.7% | 26.9% |
| Net Income ($M) | $2,530 | $3,068 | $3,131 | $3,480 |
| Diluted EPS | $3.91 | $4.98 | $5.38 | $6.34 |
| Adj. EPS | — | — | — | $8.64 |
| Interest Expense ($M) | $746 | $1,004 | $1,238 | $1,531 |
| Diluted Shares (M) | 647.9 | 616.1 | 582.1 | 549.0 |
Revenue CAGR (3yr, 2022→2025): 6.1% Net Income CAGR (3yr): 11.2% ⚠️ 2025 flag: Operating income declined YoY ($5,879M → $5,698M) despite revenue growth. Interest expense more than doubled from 2022 ($746M) to 2025 ($1,531M), consuming margin expansion. This is the debt-buyback flywheel creating earnings pressure.
Free Cash Flow
| Year | Operating CF | Capex | FCF | FCF/Share |
|---|---|---|---|---|
| 2022 | $4,618M | ($1,479M) | $3,139M | $4.84 |
| 2023 | $5,162M | ($1,388M) | $3,774M | $6.12 |
| 2024 | $6,631M | ($1,569M) | $5,062M | $8.70 |
| 2025 | $6,062M | ($1,763M) | $4,299M | $7.83 |
FCF CAGR (3yr, 2022→2025): 11.1% aggregate; 17.4% per share (buyback-amplified) ⚠️ 2025 flag: FCF declined -15% YoY ($5,062M → $4,299M) despite higher revenue, driven by higher capex and lower operating CF. The 2024 peak was exceptional; 2025 is a step back.
Shares & Capital Allocation
| Year | Basic Shares (M) | Buybacks ($M) | Net New Debt ($M) |
|---|---|---|---|
| 2022 | 630.0 | — | — |
| 2023 | 616.1 | — | ~$1,694 |
| 2024 | 564.0 | — | ~$1,720 |
| 2025 | 534.0 | $5,899 | +$2,549 |
Share count: 630M → 534M (down 15.2% in 3 years). Aggressive buyback program. Critical structure: Fiserv is borrowing to buy back shares. Net debt rose from $19.7B (2022) to $26.1B (2025). Interest expense will continue rising unless debt is reduced.
2025 Cash Deployment: | Use | Amount | % | |---|---|---| | Buybacks | $5,899M | 65.5% | | Capex | $1,763M | 19.6% | | M&A | $1,345M | 14.9% | | Dividends | $0 | 0% |
Balance Sheet
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total Assets ($M) | $83,869 | $90,890 | $77,176 | $80,133 |
| Total Debt ($M) | $21,542 | $23,236 | $24,956 | $29,123 |
| Net Debt ($M) | $19,707 | $20,949 | $22,622 | $26,087 |
| Common Equity ($M) | $30,828 | $29,857 | $27,068 | $25,792 |
| Goodwill + Intangibles ($M) | $49,226 | $48,415 | $46,524 | $47,864 |
| Tangible Book Value ($M) | ($18,398) | ($18,558) | ($19,456) | ($22,072) |
| Debt/Assets | 25.7% | 25.6% | 32.3% | 36.3% |
Tangible book value is deeply negative due to the 2019 First Data acquisition (~$22B). This is structurally normal for large fintech acquirers. Debt/assets rising trend is the watch item.
Key Ratios
| Metric | Value | Context |
|---|---|---|
| Revenue/Share (2025) | $38.60 | +12.2% CAGR vs 2022 |
| FCF/Share (2025) | $7.83 | Down from $8.70 peak |
| ROIC (GAAP, 2025) | 6.7% | Improving trend; GAAP-only (tangible ROIC n/a, negative equity base) |
| Gross Margin (2025) | 59.4% | Slight contraction from 60.8% peak |
| Operating Margin (2025) | 26.9% | Contracting (from 28.7%) |
| Net Debt/FCF | 6.1x | Elevated; rising |
| Interest Coverage (EBIT/Int) | $5,698M / $1,531M = 3.7x | Tightening but not distressed |
Earnings Surprise History
| Quarter | Actual EPS | Consensus | Surprise |
|---|---|---|---|
| Q4 2025 | $1.99 | $1.935 | +2.84% ✅ |
| Q3 2025 | $2.04 | $2.695 | -24.31% ❌ — CRASH TRIGGER |
| Q2 2025 | $2.47 | $2.479 | -0.38% ≈ inline |
| Q1 2025 | $2.14 | $2.117 | +1.08% ✅ |
Phase 1: Moat Analysis
The Anatomy of Fiserv's Moat
Fiserv has two distinct businesses with very different moat profiles:
1. Financial Solutions (Banking Technology) — Wide Moat - Serves 42% of US banks and 31% of credit unions - Core banking platforms (Premier, Precision, DNA, Cleartouch) are deeply embedded: real-time transaction processing, ACH, compliance reporting, digital banking - Client retention: consistently >95% - Contract structure: 5–7 year multi-year agreements, standard - Switching cost reality: A core banking replacement is a "multi-year, multi-million dollar ordeal" — data migration, regulatory risk, staff retraining. Banks almost never switch. - Revenue from Financial Solutions ≈ ~49% of total GAAP revenue (~$10.4B) - This is the moat. Disruption horizon: 10+ years minimum, primarily limited to de novo banks on modern stacks (which bypass legacy processors entirely)
2. Merchant Solutions (Clover + Enterprise POS) — Narrow-to-Moderate Moat - Clover: $3.3B revenue in 2025, +23% YoY. GPV ~$300B+ annualized — largest among SMB POS players (ahead of Square ~$220B, Toast ~$135B) - Bank distribution channel is the key differentiator: Clover is sold through bank branches, ISOs, and VARs — a distribution network neither Toast nor Square can replicate - Software attach creates rising switching costs: restaurants/SMBs using Clover payroll + inventory + lending + loyalty = expensive to leave - Moat risk: Toast has deeper restaurant vertical software; Square has stronger brand for micro-merchants; Stripe Terminal winning modern developers - Forced migration risk: Up to 200,000 Payeezy merchants were forcibly migrated to Clover 2023-2024 — inflating 2024 reported Clover growth metrics. Organic acquisition numbers are harder to verify.
Adversarial Stress Test
"How would a rival attack Fiserv?"
| Attack Vector | Severity | Timeline |
|---|---|---|
| Toast wins restaurants away from Clover's restaurant vertical | Medium — Toast already leads on software depth | 2-4 years |
| Adyen/Stripe win enterprise merchants with single-platform modern architecture | Medium — already happening at margin | Ongoing |
| Modern cloud-native cores (Temenos, Mambu) win de novo banks | Low near-term — does not affect 4,000+ existing community bank clients | 7-10 years |
| Argentina/emerging market tailwinds fade (ALREADY HAPPENED) | Realized — the Q3 miss | — |
| Prior CEO's execution debt creates persistent underperformance | Medium — 2026 "investment year" confirms this is real | 12-18 months |
Evergreen Rating
Banking tech: Very high (decade+). Core processing is close to an insurmountable moat for existing clients. Clover/Merchant: Medium (3-5 years). Contested, but growing via software attach and bank distribution. Combined Fiserv: Wide moat with near-term execution noise.
Phase 1: Sentiment
The October 2025 Crash — Full Anatomy
- Root cause: FISV was priced as a high-growth fintech (40x+ P/E). Argentina inflation created artificial payment volume growth (high nominal volumes from peso inflation). When Argentina normalized, management had assumed non-Argentina businesses would accelerate — they didn't.
- Q3 EPS miss: Actual $2.04 vs. $2.695 estimate = -24.3% miss. Guidance slashed from $10.15-$10.30 to $8.50-$8.60 full year.
- Execution debt revealed: Prior CEO Bisignano (departed to become Treasury Secretary) had deferred investment and cut costs to hit short-term margin targets. New CEO Lyons uncovered the damage and reset expectations all at once.
- One-day result: -44% price collapse (Oct 29, 2025). Stock went from ~$126 to ~$70 in a single session.
- Q4 recovery: Beat consensus by +2.84%. Stock stabilized $60-70 range.
2026 Guidance & Management Commentary
- Adj. revenue growth: 1-3% (down dramatically from prior ~10%)
- Q1 2026 margin: slightly below 30%; H2 recovery to 35-36%
- 2026 = "critical investment and transition year" (management's words)
- Capex guided ~$1.8B — elevated, deliberate re-investment
- Analyst EPS estimate: ~$8.14 (down ~5.8% from 2025 adj. $8.64)
New Management Team
| Role | Person | Signal |
|---|---|---|
| CEO | Michael Lyons (appointed May 2025) | Full reset approach; credible clean-slate narrative |
| CFO | Paul Todd (from GPN, Dec 2025) | Joined from direct competitor; bought stock within weeks of starting |
| Co-President | Takis Georgakopoulos | Payments tech veteran |
| Co-President | Dhivya Suryadevara | Former GM CFO |
| Independent Chairman | Gordon Nixon | New board refreshment |
Insider Buying
| Person | Action | Date | Amount |
|---|---|---|---|
| CFO Paul Todd | Purchased shares | Dec 2025 | Bought within weeks of joining |
| Chief Admin/Legal Rosman | Purchased 7,900 shares | Dec 2, 2025 | $65-70 range |
| Board member Lance Fritz | Purchased 10,000 shares | Oct 30, 2025 | $65.18 — day after crash |
| Last 30 days total | ~24,900 shares bought | — | ~$1.56M — zero insider sales |
Bullish signal. Multiple insiders putting real capital in at distressed prices within days of the crash.
Legal Overhang
Multiple securities fraud class action suits filed (class period Jul 23 – Oct 29, 2025): - Core allegation: Management raised guidance in July 2025 knowing it was "objectively difficult to achieve," then admitted this on Oct 29. Concurrent allegation: forced Payeezy-to-Clover migrations inflated growth metrics. - Firms: Hagens Berman, Berger Montague, Block & Leviton, Bernstein Liebhard - Lead plaintiff deadlines passed Jan 2026; litigation is ongoing - Risk assessment: Settlement likely 2-4 years out; typical securities fraud settlement is 2-8% of market cap losses. At 10M class shares × $60 average decline → potential ~$600M-1B exposure. Non-trivial but not existential. D&O insurance will cover a portion.
Clover Competitive Position (2026 Update)
- 160,000 US restaurant locations (vs. Toast 130,000)
- GPV $300B+ annualized (Square $220B, Toast $135B)
- International expansion: TD Bank Canada, SMCC Japan — new underpenetrated markets
- 2026 GPV growth guidance: 10-15%
- Note: 2024 organic numbers overstated due to Payeezy forced migration. Watch 2026 organic acquisition numbers closely.
Phase 2: Valuation
Applicable Models
No dividend → DDM and Dividend Yield Theory not applicable. Use Graham, Bogle, FCF-based.
Graham's Number
Formula: √(22.5 × EPS × BVPS) - GAAP EPS: $6.34 | BVPS: $48.30 - Graham's Number: $83.01 — 35% above current price - Critical caveat: BVPS includes $47.9B goodwill/intangibles; tangible BVPS is -$41.37. Treat $83 as a soft ceiling, not a reliable anchor. The Graham signal here is "not expensive," not "definitively cheap."
Bogle's Expected Return Model
Formula: Dividend Yield + EPS Growth Rate ± P/E Change - Dividend yield: 0% - EPS growth (base case): 7% recovery as transition year ends - P/E normalization: 6.79x → 12x over 5yr = ~12%/yr tailwind
| Scenario | EPS Growth | P/E Change/yr | Total Return/yr | Price in 5yr |
|---|---|---|---|---|
| Bear (H2 misses again) | 0% | -1%/yr (6.79→6x) | ~-1% | ~$58 |
| Base (H2 recovers, slow re-rate) | 7% | +10%/yr (6.79→12x) | ~17% | ~$136 |
| Bull (full recovery + re-rate) | 12% | +14%/yr (6.79→16x) | ~26% | ~$195 |
FCF-Based Fair Value
Current FCF/Share: $7.83
| Multiple | Fair Value/Share | vs. Current |
|---|---|---|
| 8x P/FCF | $62.64 | ~inline (current 7.8x) |
| 12x P/FCF | $93.96 | +53% upside |
| 15x P/FCF | $117.45 | +92% upside |
| 20x P/FCF | $156.60 | +156% upside |
12-15x P/FCF is a reasonable normalized range for a moat payments infrastructure company with 6-11% FCF CAGR. The market is pricing in zero recovery.
EV/EBITDA Bridge
| Scenario | EV/EBITDA | EV | Equity Value | Price/Share |
|---|---|---|---|---|
| Stress (H2 fails) | 5.0x | $44.8B | $18.7B | ~$35 |
| Base | 10.0x | $89.6B | $63.5B | ~$119 |
| Recovery | 12.0x | $107.5B | $81.4B | ~$152 |
(Net debt $26.1B deducted; 534M shares)
Fair Value Summary
| Method | Fair Value | Notes |
|---|---|---|
| Graham's Number | $83 | Goodwill-inflated; soft ceiling only |
| FCF at 12x | $94 | Normalized multiple for moat company |
| FCF at 15x | $117 | Pre-crash re-rate target |
| EV/EBITDA at 10x | $119 | Conservative recovery scenario |
| Bogle base (5yr) | ~$136 | Annualized ~17%/yr |
| Fair Value Range | $85–$120 | Base; 39-96% upside |
| Bull Case | $140-155 | Full re-rate |
| Bear Case | $40-55 | H2 2026 miss + further de-rating |
Phase 3: Debate
Tension: Fundamentals Pessimism vs. Moat Durability
Fundamentals says: FCF declined 15% YoY; operating income fell; interest expense doubled; debt/assets at 36% and rising; 2026 guidance implies near-zero growth. The debt-funded buyback machine is running out of room as interest expense consumes margin.
Moat says: The banking tech business — half of revenue — has never been stronger. 42% US bank penetration, 95%+ retention, 5-7yr contracts, no credible displacement threat for 10+ years. You cannot value a moat business on one bad transition year.
Resolution: The Fundamentals pessimism is real but backward-looking and transition-specific. The moat analyst wins this debate because the durable earnings engine (banking tech) has not been impaired. The prior CEO's execution debt is being corrected. Weight: 70% moat/forward, 30% current fundamentals.
Tension: Debt Risk vs. Valuation Cheapness
Risk: Net debt at $26.1B is 6.1x FCF. Interest coverage at 3.7x is not distressed but tightening. If FCF stays compressed at $4B and the company keeps borrowing to buy back stock, this gets uncomfortable.
Opportunity: At 7.8x P/FCF, even a partial re-rating to 12x doubles the stock. The company generates $4.3B in FCF annually — it can service $29B in debt without existential risk. The new CFO (Paul Todd) is unlikely to continue the borrow-and-buyback strategy aggressively.
Resolution: The debt load is real risk, not theoretical. But the FCF generation is strong enough that this is a manageable risk, not an existential one. Watch debt trajectory in 2026 — if new management begins net debt reduction, this concern shrinks meaningfully.
Phase 4: Synthesis & Verdict
What the Market Got Right
FISV was over-priced as a high-growth fintech. It should never have traded at 40x earnings. The de-rating from 40x to 7x is directionally correct — this is a mid-single-digit growth business with significant leverage, not a hypergrowth compounder.
What the Market Got Wrong
The market threw out the entire company. The banking technology moat — one of the stickiest, most defensible businesses in US financial services infrastructure — is priced at effectively zero. 42% of US banks don't leave their core processor. They just don't. That piece of the business is worth substantially more than the current EV/FCF implies.
A portfolio-specific passage was removed from the public build.
Verdict
Conviction: 7/10 — HOLD; Add $52-60
The de-rating was real and partially justified (it shouldn't have been a 40x stock). But at 7x FCF for a company with one of the widest moats in US bank technology, the pendulum has swung too far the other way. New management is credible, insiders are buying, and Clover is genuinely the largest SMB POS by volume. 2026 is a transition year — patience required.
- Add zone: $52-60 (near 52-week low)
- Hold zone: $60-80
- Review trigger: Q1 2026 earnings (date TBD, likely late April/early May). If H2 margin recovery guidance is maintained, add. If H2 is cut again, reassess the thesis entirely.
- Trim at: $100+ (target 10-15% position weight reduction)
- Exit if: Management cuts H2 2026 guidance again, OR net debt continues rising despite FCF > $4B
Key Risks
| Risk | Probability | Impact |
|---|---|---|
| H2 2026 margin recovery fails | Medium (35%) | High — another leg down to $40-50 |
| Securities class action large settlement | Low-Medium (25%) | Medium — $500M-1B hit to FCF 2027-2028 |
| Net debt continues rising | Medium-Low (30%) | Medium — interest expense > $2B compresses FCF |
| Clover organic growth below 10% in 2026 | Medium (40%) | Low-Medium — already priced in at 7x |
| Argentina/FX headwind persists | Low (20%) | Already digested; low incremental risk |
| New management fails to execute | Low (20%) | High — but insider buying reduces this probability |
Analyst Consensus
HOLD (72%) | Buy/Strong Buy 25% | Sell 3% — Broad analyst caution; no capitulation into Sell despite 68% drawdown. Price targets from Citi ($60) to consensus ~$65-80. Conservative street.
Analysis by Financebot | Manager + Fundamentals + Moat + Sentiment + Valuation | 2026-04-28